Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hailing Lin"'
Autor:
Chuihuai You, Shoujian Zang, Tianzhen Cui, Xinlu Sun, Yachun Su, Qing Lin, Hailing Lin, Youxiong Que, Wancai Que
Publikováno v:
Medicinal Plant Biology, Vol 3, Iss 1, Pp 1-10 (2024)
Gelsemium elegans is a traditional Chinese medicinal plant, with indole alkaloids as its main active ingredient. The plant can be used as medicine, mainly for pain relief, anti-inflammation and anti-tumor. Exogenous stress, such as low temperature, m
Externí odkaz:
https://doaj.org/article/4d7be0250e924499856814cb79955b84
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e30985- (2024)
Objectives: FGFR4-variant and wild-type colorectal cancer (CRC) organoids were developed to investigate the effects of FGFR4-targeted drugs, including FGFR4-IN and erdafitinib, on CRC and their possible molecular mechanism. Methods: Clinical CRC tiss
Externí odkaz:
https://doaj.org/article/8755cb01b50b45db8f6521c15881b01c
Autor:
Hailing Lin, Jiqiang Yan, Lei Yuan, Beibei Qi, Zhujing Zhang, Wanlu Zhang, Aihua Ma, Fuwan Ding
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 13, Iss 1, Pp 1-11 (2021)
Abstract Background Post-transplant diabetes mellitus (PTDM) occurs in 10–30% of kidney transplant recipients. However, its impact on mortality and graft survival is still ambiguous. Therefore, the current study aimed to analyze if PTDM increases m
Externí odkaz:
https://doaj.org/article/1d3da9fb24864ee394ed8f98db7f6f54
Autor:
Wancai Que, Zhaoyang Wu, Maohua Chen, Binqing Zhang, Chuihuai You, Hailing Lin, Zhichang Zhao, Maobai Liu, Hongqiang Qiu, Yu Cheng
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Gelsemium elegans (Gardner and Champ.) Benth. (Gelsemiaceae) (GEB) is a toxic plant indigenous to Southeast Asia especially China, and has long been used as Chinese folk medicine for the treatment of various types of pain, including neuropathic pain
Externí odkaz:
https://doaj.org/article/05478add4a5a421db6728f5c504b9baa
Autor:
Xueyong Li, Bingqing Zhang, Yu Cheng, Maohua Chen, Hailing Lin, Binglin Huang, Wancai Que, Maobai Liu, Lili Zhou, Qinyong Weng, Hui Zhang, Hongqiang Qiu
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2323 (2022)
Polymyxin B (PMB) is the final option for treating multidrug-resistant Gram-negative bacterial infections. The acceptable pharmacokinetic/pharmacodynamic target is an area under the concentration–time curve across 24 h at a steady state (AUCss,24h)
Externí odkaz:
https://doaj.org/article/fc9ed3f9d65e4da69173aadc6a96344e
Publikováno v:
Molecules, Vol 26, Iss 23, p 7145 (2021)
Gelsemium elegans Benth (GEB), also known as heartbreak grass, is a highly poisonous plant belonging to the family Loganiaceae and genus Gelsemium that has broad application prospects in medicine. This article reviews its chemical components, pharmac
Externí odkaz:
https://doaj.org/article/f565d58e655b4b41b1c65c6bc38b06c8
Autor:
Wancai Que, Hailing Lin, Xueyong Li, Bingqing Zhang, Maobai Liu, Xin Hu, Junsheng Fu, Yu Cheng, Hongqiang Qiu
Publikováno v:
International immunopharmacology. 114
Gelsemiumelegans(Gardner.Chapm.) Benth. has long been considered a traditional Chinese medicine effective against rheumatoid pain, cancer, cirrhosis, and skin diseases. Koumine (KM), the most abundant alkaloid in G.elegans Benth., demonstrates a vari
Autor:
Bingqing Zhang, Xueyong Li, Yiying Chen, Bo Chen, Yu Cheng, Hailing Lin, Wancai Que, Maobai Liu, Lili Zhou, Hui Zhang, Hongqiang Qiu, Chaoyang Wu
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 227:115291
Publikováno v:
Molecules
Molecules, Vol 26, Iss 7145, p 7145 (2021)
Molecules, Vol 26, Iss 7145, p 7145 (2021)
Gelsemium elegans Benth (GEB), also known as heartbreak grass, is a highly poisonous plant belonging to the family Loganiaceae and genus Gelsemium that has broad application prospects in medicine. This article reviews its chemical components, pharmac
Autor:
Zhujing Zhang, Fuwan Ding, Hailing Lin, Lei Yuan, Aihua Ma, Jiqiang Yan, Beibei Qi, Wanlu Zhang
Publikováno v:
Diabetology & Metabolic Syndrome
Diabetology & Metabolic Syndrome, Vol 13, Iss 1, Pp 1-11 (2021)
Diabetology & Metabolic Syndrome, Vol 13, Iss 1, Pp 1-11 (2021)
Background Post-transplant diabetes mellitus (PTDM) occurs in 10–30% of kidney transplant recipients. However, its impact on mortality and graft survival is still ambiguous. Therefore, the current study aimed to analyze if PTDM increases mortality